- Home
- ALLE vs ELAN Comparison
ALLE vs ELAN Comparison
Compare ALLE & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLE | ELAN |
|---|---|---|
| Founded | 2013 | 1954 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 11.6B |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ALLE | ELAN |
|---|---|---|
| Price | $141.43 | $23.82 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $175.00 | $27.63 |
| AVG Volume (30 Days) | 764.8K | ★ 4.6M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | ★ 9.09 | N/A |
| EPS | ★ 7.44 | N/A |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $8.55 | $8.61 |
| Revenue Next Year | $4.51 | $4.90 |
| P/E Ratio | $19.32 | ★ N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $116.57 | $8.02 |
| 52 Week High | $183.11 | $27.72 |
Technical Indicators
Market Signals| Indicator | ALLE | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 24.09 | 47.34 |
| Support Level | $136.02 | $23.72 |
| Resistance Level | $144.80 | $25.68 |
| Average True Range (ATR) | 2.90 | 0.92 |
| MACD | -0.58 | 0.03 |
| Stochastic Oscillator | 5.28 | 50.80 |
Price Performance
Historical ComparisonAbout ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.